Alternatively, it was recently reported that TG2 deletion in breast cancer cells reduced LDHA expression, and TG2 overexpression increased LDHA expression, via the MEK/ERK pathway (Xu et al., 2022). The gene discussed is TGM2; the disease is breast cancer.